The National Clinical Care Commission (the Commission) will conduct a virtual meeting on September 27, 2019. The Commission is charged with evaluating and making recommendations regarding improvements to the coordination and leveraging of programs within the U.S. Department of Health and Human Services and other federal agencies related to awareness and clinical care for at least one, but not more than two, complex metabolic or autoimmune diseases resulting from issues related to insulin that represent a significant disease burden in the United States, which may include complications due to such diseases.